![]() A61K47/14- Esters of carboxylic acids, e.g.glycerol Polyethylene glycols Poloxamers PEG/POE alkyl ethers A61K47/10- Alcohols Phenols Salts thereof, e.g.ethers, acetals, ketones, quinones, aldehydes, peroxides natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite carriers or inert additives Targeting or modifying agents chemically bound to the active ingredient A61K47/00- Medicinal preparations characterised by the non-active ingredients used, e.g.A61K45/06- Mixtures of active ingredients without chemical characterisation, e.g.A61K45/00- Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00.cortisone, dexamethasone, prednisone or aldosterone pregnane or progesterone substituted in position 21, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. A61K31/573- Compounds containing cyclopentahydrophenanthrene ring systems Derivatives thereof, e.g.estrane, estradiol substituted in position 17 alpha, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. A61K31/567- Compounds containing cyclopentahydrophenanthrene ring systems Derivatives thereof, e.g. ![]() A61K31/565- Compounds containing cyclopentahydrophenanthrene ring systems Derivatives thereof, e.g.A61K31/57- Compounds containing cyclopentahydrophenanthrene ring systems Derivatives thereof, e.g.A61K31/56- Compounds containing cyclopentahydrophenanthrene ring systems Derivatives thereof, e.g.A61K31/00- Medicinal preparations containing organic active ingredients.A61K- PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES.A61- MEDICAL OR VETERINARY SCIENCE HYGIENE.Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.) Filing date Publication date Priority claimed from US20607709P external-priority Application filed by Hal Witt, Jennifer Yoakum filed Critical Hal Witt Priority to US13/203,020 priority Critical patent/US20120046518A1/en Priority to BRPI1006984-4A priority patent/BRPI1006984A2/en Priority to CA2750530A priority patent/CA2750530A1/en Priority to CN2010800054374A priority patent/CN102291992A/en Publication of WO2010085363A1 publication Critical patent/WO2010085363A1/en Priority to US14/090,450 priority patent/US9763962B2/en Links Inventor Hal Witt Jennifer Yoakum Original Assignee Hal Witt Jennifer Yoakum Priority date (The priority date is an assumption and is not a legal conclusion. Google Patents WO2010085363A1 - Estrus synchronization preparations and effective cidr-less protocols WO2010085363A1 - Estrus synchronization preparations and effective cidr-less protocols
0 Comments
Leave a Reply. |